Two new bipartisan bills introduced by House Democrats aim to prevent the pharmaceutical industry from engaging in price-gouging on COVID-19 treatments, according to a Common Dreams report. The legislation was introduced following a recent poll that found a whopping 88 percent of Americans fear […]
Report: Drugmakers Engaging in ‘Science by Press Release’
Drugmakers are increasingly taking up a tactic to make their experimental products stand out, according to a Politico report: "science by press release." Experts tell Politico the strategy could ultimately have negative consequences. "There's a long history of pharmaceutical manufacturers […]
Public Citizen to Pharma: Stop Raising Prices During a Pandemic
Public Citizen in a recent campaign asked 20 pharmaceutical companies to halt price increases as the U.S. grapples with the COVID-19 pandemic. Letters were sent to Abbvie, Allergan, Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol Myers Squibb, Eli Lilly, Gilead Sciences, GlaxoSmithKline, […]
Report: Pharma Sees Reputation Bump Among Patient Groups
A recent survey suggests the pharmaceutical industry has seen a slight bump in reputation among patient organizations, STAT reports. The survey by PatientView found that 46 percent of patient advocacy groups believed brand-name companies had developed a better reputation last year, according to […]
Report Puts Spotlight on Pharma Transparency
FirstWord Pharma in its "Pricing Transparency in Pharma" report explores the rising demand for increased transparency. The report highlights 10 key issues "pharma needs to understand and respond to," and includes insights from experts in the field. "Concerned that confidential pricing […]
Pfizer Looks to Secure Lead in ‘Arms Race’ for Data
As top pharmaceutical companies look to tap into the wealth of health care data from things like wearables and genetic tests, Pfizer is looking to partner with a number of companies in a bid to get ahead of the competition, according to a STAT report. "We don't necessarily generate real-world […]
Report: Pharma Companies Want Lower Drug Prices, but Don’t Want to Lower Their Own
While pharma executives were making their proposals for lower drug prices during the J.P. Morgan Healthcare Conference, none were willing to cut their own prices, CNBC reports. According to the report, executives brought with them a host of proposals, including changes to Medicare and passing off […]
With $200M in Funding, Pharma Startup Wants to Bring New Drugs in ‘Sustainable Method’
With $200 million in startup funding, a new Massachusetts-based drug company called EQRx is looking to shake up the pharmaceutical landscape, according to a Forbes report. The company says it aims to develop ten new medicines over the next ten years, according to the report. "We want to get […]
Pharma Execs Support New Commitment to Patients
A group of pharmaceutical executives has pledged its support for a renewed effort to put the patient first after signing the New Commitment to Patients. "Our mission is to change the course of each individual's life for the better," the letter, which was published in STAT, states. "To achieve […]
Drugmakers Invest $2 Billion in Gene Therapy
Eleven drugmakers have allocated a combined $2 billion for gene therapy manufacturing since 2018, Reuters reports. Pfizer and Novartis, according to the report, are leading the charge with $600 million and $500 million investments respectively. "There's so little capacity and capability at […]
